Your browser doesn't support javascript.
loading
Subcutaneous bortezomib combined with weekly cyclophosphamide and dexamethasone is an efficient and well tolerated regime in newly diagnosed multiple myeloma.
Ong, Shin-Yeu; Ng, Hong Yen; Surendran, Shilpa; Linn, Yeh Ching; Chen, YunXin; Goh, Yeow Tee; Diong, Colin; Gopalakrishnan, Sathish Kumar.
Afiliação
  • Ong SY; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Ng HY; Department of Pharmacy, Singapore General Hospital, Singapore, Singapore.
  • Surendran S; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Linn YC; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Chen Y; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Goh YT; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Diong C; Department of Haematology, Singapore General Hospital, Singapore, Singapore.
  • Gopalakrishnan SK; Department of Haematology, Singapore General Hospital, Singapore, Singapore. sathish.gopalakrishnan@sgh.com.sg.
Br J Haematol ; 169(5): 754-6, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25413901
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article